Bioavailability: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
No edit summary
imported>Howard C. Berkowitz
No edit summary
Line 1: Line 1:
{{subpages}}
{{subpages}}
'''Bioavailability''' is the degree to which a drug or other substance becomes available to the target tissue after administration. <ref name=Cancerweb>{{citation
'''Bioavailability''' is the degree to which a drug, nutrient or other biologically active substance becomes available to the target tissue after administration. <ref name=Cancerweb>{{citation
  | title = Bioavailability
  | title = Bioavailability
  | url = http://cancerweb.ncl.ac.uk/cgi-bin/omd?bioavailability}}</ref> For bioavailability to be verified, there must be a chemical, biological, immunologic, or other test that verifies the concentration of the drug, or its active derivative, in the body fluids of the recipient.
  | url = http://cancerweb.ncl.ac.uk/cgi-bin/omd?bioavailability}}</ref> For bioavailability to be verified, there must be a chemical, biological, immunologic, or other test that verifies the concentration of the drug, or its active derivative, in the body fluids of the recipient.

Revision as of 14:27, 3 December 2008

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Bioavailability is the degree to which a drug, nutrient or other biologically active substance becomes available to the target tissue after administration. [1] For bioavailability to be verified, there must be a chemical, biological, immunologic, or other test that verifies the concentration of the drug, or its active derivative, in the body fluids of the recipient.

Bioequivalence covers the case where the initial distribution of different drug preparations may vary, but the duration and form of the active principle is delivered identically. [2]

References